Can you provide the last earnings date for GSK PLC?
GSK PLC (GS71.DE) last reported earnings on 2/4/2026.
FRA:GS71 • GB00BN7SWP63
Past quarterly earnings results for GSK PLC (GS71.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in GBP): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.26 | 0.23 | 8.69% | 9.91% | 8.618B | 8.726B | -1.24% | 6.17% |
| Q3 2025 | 0.55 | 0.49 | 12.80% | 10.66% | 8.547B | 8.571B | -0.28% | 6.68% |
| Q2 2025 | 0.47 | 0.43 | 7.67% | 7.14% | 7.986B | 7.989B | -0.04% | 1.29% |
| Q1 2025 | 0.45 | 0.41 | 9.85% | 4.18% | 7.516B | 7.638B | -1.60% | 2.08% |
| Q4 2024 | 0.23 | 0.20 | 18.46% | -19.72% | 8.117B | 7.983B | 1.68% | 0.81% |
| Q3 2024 | 0.50 | 0.45 | 10.89% | -1.39% | 8.012B | 8.298B | -3.45% | -1.66% |
| Q2 2024 | 0.43 | 0.39 | 11.14% | 11.86% | 7.884B | 7.695B | 2.46% | 9.84% |
| Q1 2024 | 0.43 | 0.38 | 14.88% | 16.49% | 7.363B | 7.279B | 1.15% | 5.93% |
| Q4 2023 | 0.29 | 0.29 | -1.98% | 12.02% | 8.052B | 7.513B | 7.17% | 9.16% |
| Q3 2023 | 0.50 | 0.48 | 5.56% | 7.46% | 8.147B | 7.964B | 2.30% | 4.06% |
| Q2 2023 | 0.39 | 0.36 | 7.52% | 12.14% | 7.178B | 7.032B | 2.08% | 3.59% |
| Q1 2023 | 0.37 | 0.34 | 8.62% | -8.92% | 6.951B | 6.634B | 4.78% | -3.32% |
| Q4 2022 | 0.26 | 0.23 | 13.62% | -19.38% | 7.376B | 7.563B | -2.47% | 4.24% |
| Q3 2022 | 0.47 | 0.41 | 14.45% | 2.51% | 7.829B | 7.555B | 3.63% | 18.14% |
| Q2 2022 | 0.35 | 0.30 | 16.49% | -1.49% | 6.929B | 6.702B | 3.39% | 18.69% |
| Q1 2022 | 0.41 | 0.39 | 4.62% | 41.92% | 7.19B | 9.265B | -22.40% | -3.07% |
| Q4 2021 | 0.32 | 0.32 | 1.36% | 9.87% | 7.076B | 9.782B | -27.66% | -19.03% |
| Q3 2021 | 0.46 | 0.37 | 22.51% | 2.81% | 6.627B | 8.986B | -26.25% | -23.35% |
| Q2 2021 | 0.35 | 0.26 | 35.82% | 46.35% | 5.838B | 7.785B | -25.01% | -23.43% |
| Q1 2021 | 0.29 | 0.28 | 3.70% | -38.77% | 7.418B | 8.12B | -8.65% | -18.39% |
| Q4 2020 | 0.29 | 0.30 | -2.81% | - | 8.739B | 9.001B | -2.91% | - |
| Q3 2020 | 0.45 | 0.39 | 13.09% | - | 8.646B | 9.034B | -4.29% | - |
| Q2 2020 | 0.24 | 0.26 | -8.23% | - | 7.624B | 7.953B | -4.14% | - |
| Q1 2020 | 0.47 | 0.40 | 18.15% | - | 9.09B | 8.949B | 1.58% | - |
Notes
GSK PLC (GS71.DE) last reported earnings on 2/4/2026.
GSK PLC (GS71.DE) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, GSK PLC (GS71.DE) has beaten EPS estimates in 4 out of 4 releases.